|
|
Article: New Findings From Two Studies on Lybrel Presented at ACOG.
- Article from:
- PR Newswire
- Article date:
- May 8, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
-Data Evaluate the Time to Return to Menses After Stopping Lybrel and Safety and Efficacy-
MADISON, N.J., May 8 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , announced today that two new scientific abstracts relating to the investigational, combination oral contraceptive Lybrel(TM) (90 micrograms levonorgestrel/20 micrograms ethinyl estradiol tablets) were presented this week at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical Meeting in Washington, D.C.
The first scientific abstract reported on the return to menstruation after stopping the non-cyclic oral contraceptive (Lybrel). The study showed ...